[Progress in Medicinal Chemistry] Progre
โ
Allen, Michael J.
๐
Article
๐
2006
๐
Elsevier
๐
English
โ 31 KB
The perceived lack of drug discovery productivity in recent times has led to much debate in the pharmaceutical/biotechnology industry as escalating R&D costs are not being matched by increased output. Few observers doubt that selecting the right targets, ie those which are critical to disease pathol